CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:T cell exhaustion landscapes and therapeutic modulation in cancer immunity.
T cell exhaustion landscapes and therapeutic modulation in cancer immunity.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
T细胞耗竭是解释为何持续抗原暴露和免疫细胞浸润仍无法阻止抗肿瘤T细胞应答失败的核心理论框架。耗竭并非单一的功能障碍终点,而日益被理解为经历抗原刺激的CD8+ T细胞状态所构成的、有组织且动态变化的连续谱;不同状态在增殖能力、效应潜能、表观遗传限制、代谢适能及肿瘤内空间分布方面各不相同。这一观点具有重要治疗意义,因为临床相关干预可重塑耗竭状态的组成和功能,而不必完全恢复为非耗竭状态。本综述考察从祖细胞样到终末状态的耗竭T细胞谱系组织,并讨论TOX相关存活程序、表观遗传固定,以及肿瘤造成的代谢和空间限制如何在慢性刺激下稳定耗竭命运。
我们重点介绍祖细胞样耗竭T细胞在维持治疗应答中的作用,解释为何免疫检查点阻断后的功能重振往往是部分性的而非彻底逆转,并评估调节耗竭动态的新兴策略,包括联合免疫治疗和CAR-T 细胞工程化控制系统。
总体而言,这些概念支持将耗竭视为一种可测量、可维持并可选择性重新引导的受限状态系统,而非二元性缺陷。明确哪些耗竭状态仍可被有效控制、以及在何种条件下可控,对于开发更持久、机制依据更充分的癌症免疫疗法至关重要。
T cell exhaustion is a central framework for explaining why antitumor T cell responses often fail despite persistent antigen exposure and immune infiltration. Rather than a single dysfunctional endpoint, exhaustion is increasingly understood as a structured and dynamic continuum of antigen-experienced CD8 + T cell states that differ in proliferative capacity, effector potential, epigenetic constraint, metabolic fitness, and spatial distribution within tumors.
This view has major therapeutic implications because clinically relevant interventions can remodel exhausted-state composition and function without fully restoring a non-exhausted identity. In this review, we examine the organization of exhausted T cell states from progenitor-like to terminal compartments and discuss how TOX-linked survival programs, epigenetic fixation, and tumor-imposed metabolic and spatial constraints stabilize exhausted fate under chronic stimulation.
We highlight the role of progenitor exhausted T cells in sustaining therapeutic responsiveness, explain why reinvigoration after checkpoint blockade is often partial rather than transformative, and evaluate emerging strategies to modulate exhaustion dynamics, including combination immunotherapy and engineered control systems in CAR T cells.
Together, these concepts support a shift from viewing exhaustion as a binary defect to understanding it as a constrained state system that can be measured, preserved, and selectively redirected. Defining which exhausted states remain productively controllable, and under what conditions, will be essential for developing more durable and mechanistically informed cancer immunotherapies.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。